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 Glaucoma is one of the leading causes of blindness in
the world [1,2]. One of the main risk factors for primary open-
angle glaucoma is elevated intraocular pressure (IOP); and
lowering IOP is the only effective therapy currently available
[3]. It has been known for nearly 40 years that the locus of this
hydrodynamic disease resides in the trabecular meshwork
(TM) outflow pathway [4-6], but there are currently no spe-
cific treatments targeted to the TM [2]. Most potential TM
drugs, e.g., ethacrynic acid (ECA) that influences the cytosk-
eleton in TM cells, are currently delivered topically, which is
limited by the induced corneal toxicity observed at the drug
dosage required for adequate transport across the cornea [7,8].
One alternative approach to TM drug delivery, which can
avoid the cornea toxicity, would be to deliver drugs through
the sclera. To this end, we quantified the transscleral perme-
ability and diffusion coefficients of ECA in fresh porcine sclera.
To determine mechanisms of ECA transport in the sclera, we
also investigated the transscleral transport of sodium fluores-
cein (NaF), a highly hydrophilic molecule, and compared the
results with those of ECA. Although their molecular weights
are similar (i.e., 303 versus 376), we observed that the por-
cine sclera was more permeable to ECA than NaF. In addi-
tion, the diffusion coefficients of ECA and NaF were insensi-
tive to changes in volume fraction of viable cells in the sclera.
To quantitatively understand mechanisms of the difference in
the diffusion coefficients between ECA and NaF, we devel-
oped a mathematical model to simulate diffusion and binding
of these molecules in the sclera, and compared the simulation
results with the experimental data.
METHODS
Preparation of fresh porcine sclera:  Freshly enucleated por-
cine eyes were obtained locally from a slaughterhouse and
stored at 4 °C. The time interval between porcine sacrifice
and the use of eyes in transport experiments was approximately
8 h. During the experiments, the adherent episcleral tissues
were carefully removed and the eyes were bisected along the
sagittal plane. The cornea, limbus, optic nerves, choroid, and
retina were thoroughly excised with minimal damage of the
sclera. The prepared scleras were used either immediately in
our experiments or stored for up to 3 days at 4 °C. The thick-
ness of the sclera was measured using a digital caliper. A cir-
cular piece of the sclera, approximately 11 mm in diameter,
was dissected using sterile curved scissors and immediately
mounted in a diffusion apparatus (Figure 1). A rubber O-ring
with an inner diameter of 6.93 mm was then placed on the
episcleral side of the tissue to prevent leakage of medium
through the junction of the two chambers in the apparatus.
The data were discarded if any leakage was observed.
Volume fraction and viability of cells in the sclera:  The
methods for quantification of volume fraction and viability of
cells in biological tissues have been described in previous stud-
ies [9-11]. In brief, 50 mg of scleral tissue was treated with
150 µl protease (Sigma, St. Louis, MO) in 1,350 µl DMEM at
37 °C for 1 h. The suspension was centrifuged at 3,000 rpm
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243for 3 min to remove the protease. The tissue pellet was then
resuspended in 1,350 µl DMEM containing 300 µl collage-
nase (type IA; Sigma) at 37 °C until they were fully digested.
The numbers of dead and viable cells in the suspension were
quantified using the LIVE/DEAD assay (Molecular Probes,
Eugene, OR) [9-11]. The viability of cells was defined as the
number of viable cells divided by the total number of cells
(viable + dead) observed under a fluorescence microscope.
The volume fraction of cells was calculated as (πdcell
3/6)Ncell/
(Ctissue/ρtissue), where dcell is the cell diameter and ρtissue is the
mass density of scleral tissues. They were assumed to be 10
µm and 1 g/cm3, respectively. Ncell is the number of cells per
unit volume of the suspension measured using a hemocytom-
eter, and Ctissue is the tissue weight per unit volume of the sus-
pension that was equal to 30 mg/ml in our experiments. All
measurements were repeated four times.
Dialysis experiment:  The equilibrium dialysis method
was used to investigate nonspecific binding of NaF and ECA
to scleral tissues. In the experiment, fresh porcine scleral tis-
sues were first digested completely using the method described
above for cell viability, except that the DMEM was replaced
by phosphate-buffered saline (PBS) containing Na2HPO4 and
KH2PO4. To minimize the binding of NaF and ECA to the
dialysis membrane, we used two different membrane materi-
als: cellulose ester for NaF and regenerated cellulose for ECA
(Float A Lyzer; Spectrum Laboratories Inc., Los Angeles, CA).
The molecular cutoff sizes of these membranes were 2,000
Da and 3,500 Da, respectively. The membranes were dispensed
overnight in deionized water at 4 °C to remove the preserva-
tive (i.e., sodium azide). NaF (or ECA) in PBS and the solu-
tion of digested tissues were prepared and then mixed at 30
min before each dialysis experiment to ensure that the bind-
ing between NaF (or ECA) and the tissues had reached equi-
librium. The total volume of the mixture was 1,650 µl, in which
the concentration of digested tissues was 30 mg/ml and the
concentration of NaF (or ECA) varied in experiments. They
were 25, 50, 75, 100, 200, 400, 1000, 2000, or 5000 µM for
NaF and 0.05, 0.1, 0.3, 0.6, 1, 2, 5, 10, or 16.5 mM for ECA.
The mixture was added into the dialysis tubing that was placed
in 25 ml of PBS stirred with a magnetic bar at 4 °C for 72 h
when the concentration equilibrium across the dialysis mem-
brane was reached for the unbound NaF and ECA molecules.
This equilibrium time (i.e., 72 h) was predetermined in a con-
trol experiment in which the scleral tissues were absent in the
dialysis tubing and the concentrations of NaF (or ECA) in
both the tubing and the buffer were monitored intermittently
until they were approximately equal to each other. At equilib-
rium, the concentration of unbound NaF (or ECA) in the di-
alysis tubing was presumably uniform and equal to the con-
centration of NaF (or ECA) in the buffer outside the tubing.
The concentration of NaF in the buffer and the total con-
centration of NaF (bound and unbound) in the dialysis tubing
were measured using the fluorescence microscopy technique
described below in the diffusion experiment. The concentra-
tions of ECA in the buffer and the dialysis tubing were mea-
sured using an HPLC method [12], in which the mobile phase,
consisted of H2O, acetonitrile, and acetic acid with a volume
ratio of 50:50:1, was injected into an HPLC column (Inertsil
ODS-3 5U, 4.6 mm i.d.x250 mm; Varian Inc., Palo Alto, CA)
at the flow rate of 1.0 ml/min. All sample solutions were fil-
tered through a 0.20 µm syringe filter (VWR, West Chester,
PA) before injecting into the HPLC system. The volume of
injection was 40 µl and the running time was set at 40 min.
The absorbance of samples at 230 nm was converted to the
ECA concentration via a linear calibration curve. It was pos-
sible that some digested tissues were filtered out by the sy-
ringe filter before injecting into the HPLC system. However,
the amounts of NaF and ECA bound to cells in the sclera were
negligible compared to those bound to extracellular matrix
since the volume fraction of cells was <1% in the sclera (see
the data in the Results section). To determine the amounts of
matrix molecules that were removed during the filtering pro-
cess, we performed a control experiment, in which the con-
centration of NaF in the dialysis tubing was measured using
both the fluorescence microscopy technique and the HPLC
method. We observed that these methods resulted in the same
concentration of NaF, indicating that the digested extracellu-
lar matrix molecules were not filtered out significantly.
Diffusion experiment:  An Ussing-type diffusion apparatus was
built to measure the diffusion coefficients of ECA and NaF in
the sclera (Figure 1). The “choroid chamber,” facing the in-
traocular side of the sclera, was filled with 6 ml of PBS. The
“episcleral chamber,” facing the episcleral side of the tissue,
was filled with a solution (20 ml) of ECA, NaF, or a mixture
of ECA and NaF, prepared at 4 °C, using PBS. The concentra-
tion was 0.6 mM for ECA and 1, 2, 4, 5, 6, or 8 mg/ml for
NaF. In the mixture, the concentrations of ECA and NaF were
0.6 mM and 5 mg/ml, respectively. All solutions were freshly
prepared before each diffusion experiment and the pH of these
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Figure 1. Schematic of the Ussing-type diffusion apparatus.  The
sclera was mounted between the two chambers with the intraocular
side of the sclera facing the choroid chamber (8 ml in volume) and
the episcleral side facing the episcleral chamber (30 ml in volume).
The solutions in both chambers were stirred continuously by mag-
netic bars and the temperature was maintained at 4 °C in all experi-
ments.
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solutions was between 6.84 and 6.95. The top surfaces of so-
lutions in both chambers were maintained approximately at
the same height to avoid a hydrostatic pressure gradient across
the tissue. As a result, convection of ECA and NaF across the
sclera was negligible. Solutions in both chambers were stirred
continuously with magnetic bars actuated at 60 rpm. All dif-
fusion experiments were conducted at 4 °C and the concentra-
tions of ECA and NaF in the choroid chamber were moni-
tored intermittently for up to 14 h through the following pro-
cedures.
For ECA, samples of solutions (1 ml) in the choroid cham-
ber were collected and placed in micro-quartz cuvettes
(Semimicro-quartz with Suprasil quartz windows; Fisher Sci-
entific Inc., Pittsburgh, PA) at 10, 20, 30, 45, 60, 90, 120, 180,
and 240 min. Absorbances of ECA at 230 nm were measured
at room temperature (25 °C) using a UV spectrophotometer
(model 8452A Diode Array Spectrophotometer; Agilent Tech-
nologies, Santa Clara, CA). The absorbances were converted
to concentrations via a linear calibration curve. After each
measurement, the collected sample was placed back into the
choroid chamber to minimize the disturbance of the experi-
mental system. For NaF, samples of solutions (<1 µl) were
collected from the choroid chamber every hour for up to 14 h,
using glass capillaries (Microslides, 0.1x1.0 mm I.D.;
VitroCom Inc., Mt. Lks., NJ), and stored in a dark environ-
ment at room temperature until measurement. Fluorescence
intensities of NaF were quantified via a fluorescence micro-
scope (Axiovert 100; Zeiss, Thornwood, NY) equipped with
a photomultiplier tube (model 9658B; Thorn EMI Electron
Tubes, Rockaway, NJ) and a filter set for fluorescein (Omega
Optical Inc., Brattleboro, VT). The intensities were measured
at three different locations along each capillary and the aver-
age intensities were converted to concentrations via a linear
calibration curve. The calibration curves for both ECA and
NaF were checked periodically and the changes observed were
<10% in all experiments.
Determination of apparent permeability and diffusion co-
efficients of ECA:  After an initial time delay, we observed
that the concentration of ECA in the choroid chamber was
approximately a linear function of time, indicating that the
flux of ECA across the sclera had reached a steady state. The
slope of the curve (∆Ct/∆t) was determined by linear regres-
sion of the concentrations at different time points. The square
of the correlation coefficient, r2, in the regression was >0.96.
The apparent transscleral permeability coefficient, Papp, and
the apparent diffusion coefficient, Dapp, at the steady state were
calculated as;
where A is the exposed surface area of the sclera, which
is equal to the area surrounded by the rubber O-ring (0.377
cm2), V is the volume of solution in the choroid chamber (6
ml), δ is the thickness of the sclera, and C0 is the concentra-
tion of ECA in the episcleral chamber.
Determination of diffusion coefficient and binding con-
stants of NaF:  In contrast to the data of ECA described above,
the concentration of NaF in the choroid chamber was a non-
linear function of time even after the initial time delay (see
the Results section), indicating that the transport had not yet
reached a steady state and that the steady-state analysis based
on Equations 1 and 2 was invalid for determining the appar-
ent diffusion coefficient of NaF. In addition, we observed in a
preliminary study that NaF transport in the sclera was signifi-
cantly hindered by the binding of NaF to scleral tissues. There-
fore, we developed a new method to determine the diffusion
coefficient and the binding constants of NaF. The new method
involved two experimental groups. In the first group, we mea-
sured the concentration of NaF in the choroid chamber as a
function of time, following the same procedure as that de-
scribed in the previous section. In the second group, the sclera
was removed from the diffusion apparatus at 6 h after NaF
was added into the episcleral chamber. The sclera was mounted
vertically on a specimen block and sectioned into 10 µm slices
using a cryostat (HM 505E; Microm, Kalamazoo, MI). For
each sclera, 200 line profiles of fluorescence intensities across
the tissue were measured, using the fluorescence microscope
mentioned above and a CCD camera (CoolSNAP-Pro; Media
Cybernetics, Silver Spring, MD). These profiles were then
averaged; and the average profile was normalized by its maxi-
mum value. The normalized profile and the temporal profile
of NaF in the choroid chamber were fit sequentially by the
mathematical model described below. The nonlinear curve-
fitting yielded the diffusion coefficient and the binding con-
stants of NaF.
Mathematical model of molecular transport across the
sclera:  The governing equation for one-dimensional, time-
dependent transport of NaF is;
where t is the time, x is the distance, Dsc is the diffusion
coefficient of NaF in the sclera, δ is the thickness of the sclera,
Cf is the concentration of unbound NaF, and Ct is the total
concentration of bound (Cb) and unbound NaF in the tissue,
i.e.;
Equation 3 is valid for diffusion in dilute solutions or tis-
sues in which the diffusion coefficient is independent of the
concentration. To verify it, we performed a preliminary ex-
periment and observed that the temporal profile of NaF con-
centration in the choroid chamber was independent of the ini-
tial concentration of NaF in the episcleral chamber ranging
from 1 to 8 mg/ml.
245The binding process has been modeled in a previous study
of sulforhodamine diffusion in the sclera [13], in which the
concentration of available binding sites is assumed to be much
larger than the local concentration of sulforhodamine. In this
case, the binding kinetics can be modeled as a first order chemi-
cal reaction. However, we observed that the concentration of
bound NaF was a nonlinear function of the concentration of
unbound NaF in the solution of enzymatically digested scleral
tissues (see the Results section), indicating that the local con-
centration of NaF was comparable to the concentration of avail-
able binding sites. Therefore, we modeled the binding of NaF
to scleral tissues as a second order chemical reaction. In addi-
tion, we assumed that the binding process was much faster
than diffusion, i.e., the binding reaction was at a quasi-equi-
librium state [13]. Taken together;
where Bmax is the apparent maximum binding capacity
and KD is the apparent equilibrium dissociation constant [14].
Substituting Equations 4 and 5 into Equation 3 yields;
The initial condition was Cf=0 at t=0. The boundary con-
ditions were determined as follows. The concentration of NaF
in the choroid chamber was much less than that in the sclera
in our experiments. Thus, it is negligible in the transport analy-
sis (i.e., Cf=0 at x=δ). There existed a concentration boundary
layer (or unstirred layer) at the tissue/solution interface in the
episcleral chamber. The thickness of the boundary layer in the
episcleral chamber was close the thickness of sclera, which
was estimated by measuring the space between the yellow
solution of NaF and the surface of sclera. The Stokes-Einstein
equation predicts the diffusion coefficient of NaF in water at
4 oC to be 2.89x10-6 cm2/sec [15], which was at least one order
of magnitude higher than the apparent diffusion coefficient in
the sclera observed in this study. Therefore, the concentration
drop across the boundary layer was negligible compared to
that across the sclera, i.e., Cf=C0 at x=0, where C0 is the con-
centration of NaF in the episcleral chamber.
Equation 6 with the initial and boundary conditions de-
scribed above was solved numerically using a finite differ-
ence method. The value of δ was measured for each sclera
used in our experiment. The values of Dsc, Bmax, and KD were
determined by using the simulation results to fit the experi-
mental data of NaF. The procedures for nonlinear curve-fit-
tings are as follows. First, the predicted concentration profile
at 6 h was used to fit the spatial distribution data (see the pre-
vious section) to determine the values of Dsc, Bmax, and KD in
individual tissue sections from three scleras. To verify the re-
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sult of Dsc, equation 6 with Bmax and KD fixed at their mean
values from three scleras was solved again to fit the temporal
profile of NaF in the choroid chamber. The fitting yielded a
new value of Dsc, which was consistent with that determined
by fitting the spatial distribution data (see the Results sec-
tion).
Statistical Analysis:  An unpaired Mann-Whitney U test
was used to compare data from different groups. The differ-
ences were considered to be statistically insignificant if p>0.05.
All data are reported as mean±SD.
RESULTS
Thickness of sclera and volume fraction and viability of
cells:  The thickness of the porcine sclera in our experiments
ranged from 0.53 mm to 1.56 mm with a mean±SD of
1.01±0.26 mm (n=28). The volume fraction and the viability
of cells are shown in Table 1. In fresh scleras, they were 0.8%
and 95%, respectively, i.e., the volume fraction of viable cells
was 0.76%. For scleras stored at 4 °C for 72 h, the volume
fraction of viable cells was reduced to 0.03%, which was only
4% of that in fresh scleras. When the temperature was increased
to 37 °C, more dead cells were observed in the sclera (Table
1).
Binding of ECA and NaF to enzymatically digested scleral
tissue:  The equilibrium binding between NaF (or ECA) and
enzymatically digested scleral tissue was determined for 9 dif-
ferent initial concentrations using the dialysis method (see the
Methods section). We measured both the total concentration
(CTd) of NaF (or ECA) in the dialysis tubing and the concen-
tration of the same molecule in the buffer outside the dialysis
tubing (CUb). At equilibrium, the concentration of unbound
NaF (or ECA) in the dialysis tubing (CUd) should be uniform
and equal to CUb. Thus, the concentration of bound NaF (or
ECA) in the dialysis tubing (CBd), defined as CTd-CUd, is equal
to CTd-CUb. For NaF, CBd increased nonlinearly with increas-
ing CUd (Figure 2). These data could be fit by equation 5, which
yielded the values of Bmax and KD to be 1.44 mM and 0.11
mM, respectively. We also compared the binding of NaF to
enzymatically digested versus mechanically homogenized tis-
sues and observed no difference between these two groups in
terms of Bmax and KD, indicating that the enzymatic digestion
did not create additional binding sites for NaF in the sclera.
The value of Bmax for NaF has to be corrected when it is used
TABLE 1. VOLUME FRACTION AND VIABILITY OF CELLS IN SCLERAS
STORED AT DIFFERENT TEMPERATURES AND FOR DIFFERENT TIME
PERIODS
The data are reported as mean±SD.
246for binding analysis in the sclera, since the tissue concentra-
tion was only 30 mg/ml in the dialysis tubing but equal to the
mass density in the sclera. If the mass density is assumed to
be 1 g/ml, the value of Bmax will be 48 mM in the sclera. For
ECA, CTd was statistically the same as CUb for all 9 different
initial concentrations, indicating that binding of ECA to scleral
tissues was negligible.
Diffusion coefficient of ECA:  The steady state analysis
of transscleral transport resulted in the apparent permeability
and diffusion coefficients of ECA, which were 42.1±8.2x10-
6cm/s and 48.5±15.1x10-7cm2/s (n=9), respectively. These data
were approximately equal to the true permeability and diffu-
sion coefficients of ECA in the sclera since there was minimal
binding of ECA to scleral tissues. When ECA diffused simul-
taneously with NaF through the same scleras, the permeabil-
ity and diffusion coefficients of ECA were 45.4±11.3x10-6cm/
s and 41.2±11.3x10-7cm2/s (n=7), respectively. The changes
were statistically insignificant (p>0.05), indicating that NaF
had no effects on the permeability and diffusion coefficients
of ECA. In addition, the permeability coefficient of ECA was
independent of the time period (4 h versus 3 days) and the
temperature (4 oC versus 37 °C) of scleras storage (data not
shown), indicating that ECA diffusion was insensitive to cell
damage in the tissue.
Spatial distribution of NaF in the sclera:  Typical images
of a tissue section with trans- and epi-illuminations are shown
in Figure 3A and Figure 3B, respectively. The transscleral pro-
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Figure 2. Equilibrium binding of sodium fluorescein (NaF) to enzy-
matically digested scleral tissue in the dialysis experiment.  The con-
centration of bound NaF was determined as a function of the concen-
tration of unbound (or free) NaF in the dialysis tubing. In the experi-
ments, the concentration of scleral tissue in the dialysis tubing was
30 mg/ml. The symbol represents the data from experiments with 9
different initial concentrations of NaF in the dialysis tubing. The solid
curve shows the nonlinear curve-fitting based on Equation 5, which
yielded the values of Bmax and KD for NaF to be 1.44 mM and 0.11
mM, respectively.
Figure 3. Spatial distribution of sodium fluorescein (NaF) in the sclera.
The sclera was frozen and sectioned into 10 µm slices when the mix-
ture of NaF (5 mg/ml) and ethacrynic acid (ECA; 0.6 mM) diffused
through it for 6 h. Images of a typical section with trans- and epi-
illuminations are shown in A and B, respectively. In B, B indicates
the right boundary of the tissue section. The normalized distribution
of the fluorescence intensity in the epi-illuminated section is shown
as open circles in C. It was a function of penetration depth of NaF
from the left to the right. The data points were fit by the normalized
total concentration of NaF at 6 h in the sclera (Ct), based on the math-
ematical model described in the Methods section. The result of curve-
fitting is shown as the solid curve in C.
247file of fluorescence intensity in Figure 3B was measured and
fit by the mathematical model described in the Methods sec-
tion. The result of curve-fitting is shown in Figure 3C, which
yielded values of Dsc, Bmax, and KD to be 2.8x10-7 cm2/s, 80
mM, and 3 mM, respectively. The mean±SD of these param-
eters from three tissue sections were 3.3±0.6x10-7 cm2/s, 80±5
mM, and 2.5±0.5 mM, respectively. The value of Bmax was
67% larger than that (i.e., 48 mM) determined by the dialysis
method in digested tissues; and the value of KD was one order
of magnitude higher than that from the dialysis experiment.
Mechanisms for explaining the discrepancy will be discussed
later.
Temporal profiles of ECA and NaF concentrations in the
choroid chamber:  To further evaluate the diffusion coeffi-
cients of ECA and NaF in the sclera, we simulated transport
of ECA and NaF across the sclera, using the mathematical
model described in the Methods section and calculated the
temporal profiles of ECA and NaF in the choroid chamber.
These profiles were also measured experimentally; and the
data were fit by the simulation results. Typical results of the
curve-fitting are shown in Figure 4. In the curve-fitting, we
assumed that the binding was negligible for ECA and that the
binding constants, Bmax and KD, for NaF in all scleras were 80
mM and 2.5 mM, respectively. Therefore, only the values of
diffusion coefficients were obtained after curve-fitting. For
ECA, it was statistically the same as the apparent diffusion
coefficient determined by using equation 1 (data not shown),
which indicated that ECA diffusion was at a steady state after
a short time period at the beginning of the experiment. For
NaF, the mean±SD of Dsc in all scleras are shown in Figure 5.
In scleras stored at 4 °C for 4 h, it was 5.23±1.93x10-7 cm2/s
(n=8). The diffusion coefficient was not affected by increas-
ing in the storage period from 4 h to 3 days (5.68±4.57x10-7
cm2/s [n=4]) or co-diffusion with ECA through the same sclera
(5.40±2.76x10-7 cm2/s [n=11]). These data indicated that NaF
diffusion was insensitive to changes in the volume fraction of
cells in tissues.
DISCUSSION
 We investigated ECA and NaF diffusion in the porcine sclera
and observed that ECA diffused approximately 8 times faster
than NaF, although their molecular weights were close to each
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Figure 4. Temporal profiles of sodium fluorescein (NaF) and
ethacrynic acid (ECA) concentrations in the choroid chamber.  A: A
typical temporal profile of NaF concentration in the choroid cham-
ber. B: A typical temporal profile of ECA concentration in the chor-
oid chamber. The symbols denote the experimental data normalized
by the initial concentrations of NaF (5 mg/ml) and ECA (0.6 mM),
respectively, in the episcleral chamber. The solid curves show the
curve-fitting based on the mathematical model described in the Meth-
ods section.
Figure 5. The diffusion coefficient of sodium fluorescein (NaF) in
the sclera.  The data were obtained through the curve-fitting shown
in Figure 4A. The bar and error bar represent mean and SD, respec-
tively. The diffusion coefficient of NaF was 5.23±1.93x10-7 cm2/s
(n=8) in scleras stored at 4 °C for 4 h, 5.68±4.57x10-7 cm2/s (n=4) in
scleras stored at 4 °C for 3 days, or 5.40±2.76x10-7 cm2/s (n=11)
when NaF diffused simultaneously with ethacrynic acid (ECA)
through the same sclera. There were no statistically significant dif-
ferences between any two groups (p>0.05).
248other (303 versus 376). In addition, we observed that the dif-
fusion coefficients of ECA and NaF were insensitive to cell
shrinkage caused by ECA during the diffusion experiments
and cell damage caused by the storage of tissues ex vivo be-
fore the experiments, presumably due to the fact that the vol-
ume fraction of cells in the sclera was only about 1%. There-
fore, the hindrance of ECA and NaF diffusion in scleral tis-
sues was mainly caused by extracellular matrix and soluble
proteins in interstitial fluid.
Effect of binding on transscleral transport:  We observed
that NaF could bind strongly to scleral tissues. The binding
was likely to be mediated through charge/charge interactions
since fluorescein has three dissociation constants that corre-
spond to three pKa values: 2.13, 4.44, and 6.36, respectively
[16,17]. At pH 7, the anionic forms of NaF may bind to posi-
tively charged extracellular matrix molecules (e.g., collagens)
and proteins dissolved in interstitial fluid. The binding may
effectively reduce the flux of NaF in tissues before the steady
state of diffusion was reached. On the other hand, the binding
of ECA to scleral tissues could not be detected. The differ-
ence in the binding between NaF and ECA could also be ob-
served directly in terms of the time lag defined as the time
period from t=0 to the time point when the concentration in
the choroid chamber started to increase rapidly with time (see
Figure 4). It was >5 h for NaF but 5-7 min for ECA. To quan-
titatively understand effects of binding on transscleral trans-
port, we developed a mathematical model to numerically simu-
late the process. The simulated time lags for both ECA and
NaF were consistent with the experimental data (data not
shown). In the rapid increase phase of the concentration in the
choroid chamber, the slope of the curve was used to calculate
the apparent diffusion coefficient, Dapp. It increased with time
and should eventually reach its maximum level when the dif-
fusion is at the steady state. If the concentration boundary layer
is negligible, which was the case in this study, the maximum
Dapp is equal to Dsc, the true diffusion coefficient in the sclera.
This trend in Dapp can be predicted by equations 3 through 6.
At the steady state, the binding has no effects on the transscleral
diffusion.
The binding constants of NaF determined in the study
depended on the experimental methods, as shown in the Re-
sults section. The values of Bmax and KD determined from the
spatial distribution of NaF in the sclera were 67% and one
order of magnitude, respectively, higher than those from the
dialysis experiment. These discrepancies are likely to be caused
by the difference in binding mechanisms between these two
methods. During the diffusion in the sclera, NaF binds to fixed
cationic groups on extracellular matrix as well as cationic
groups on mobile proteins dissolved in interstitial fluid. If the
distances between adjacent cationic groups are larger than the
diameter of NaF, the binding of NaF to these groups is monova-
lent. Meanwhile, the binding of NaF to other cationic groups
in the sclera can be either monovalent, bivalent, or trivalent
since NaF has 3 anionic groups at pH>6.4 [16,17]. In the so-
lution of digested tissues, all charged molecules are freely
mobile, thereby making it easier for NaF to have bivalent or
trivalent binding to cationic groups. It has been shown in the
literature that the apparent equilibrium dissociation constant
KD for bivalent binding can be several orders of magnitude
smaller than that for monovalent binding to the same substrates
[18]. And the trivalent binding can further reduce the value of
KD. The bivalent and trivalent binding will also reduce the
number of bound NaF molecules and consequently the value
of Bmax. Therefore, the binding valency is likely to be a mecha-
nism to partly explain the differences in Bmax and KD men-
tioned above.
Effects of hydrophobicity and charge on molecular diffu-
sion:  The 8 fold difference in the diffusion coefficients be-
tween ECA and NaF could be partly due to the differences in
their hydrophobicities and charges since the molecular weights
of ECA and NaF are similar (303 versus 376). NaF is soluble
in water and has three pKa values as discussed above. In con-
trast, ECA is sparingly soluble in water and aqueous acids. It
has only one pKa at 3.50 [19]. The pKa values of these mol-
ecules indicated that the amount of the unionized form of ECA
was approximately four orders of magnitude higher than that
of NaF in PBS at pH 7, i.e., NaF was much more soluble than
ECA in PBS. In addition, the hydrophobicity can be deter-
mined directly by the logarithm of the distribution coefficient
(logD), which is equal to the partition coefficient times the
fraction of the unionized form [16]. The logD of ECA be-
tween ether and water is 0.05 at pH=7.4 [19], and the logD of
NaF between octanol and water at pH=7.4 was -4.28 [16].
The solubilities in ether and octanol are on the same order of
magnitude for many small molecules [20]. Hence, NaF is ap-
proximately four orders of magnitude more hydrophilic than
ECA. The relatively hydrophobic nature of ECA may allow it
to diffuse through both intracellular and extracellular space
whereas NaF can diffuse only through the interstitial fluid
space. However, the volume fraction of cells in the sclera was
less than 1% (see Table 1). As a result, the hydrophobicity
should have minimal effects on the rate of diffusion compared
to the charge of molecules. As discussed above, charge can
mediate binding of NaF to immobile structures (e.g., extracel-
lular matrix) or soluble proteins in tissues, which hinders dif-
fusion at unsteady state. Meanwhile, the charge of solutes can
affect the diffusion through mechanisms that are independent
of binding. Data in the literature have shown that negatively
charged molecules diffuse slower in the microvessel wall com-
pared to neutral or positively charged molecules [21-23], pre-
sumably due to charge/charge repulsion since the basement
membrane and the glycocalyx on the luminal surface of the
microvessel wall are negatively charged. The charge/charge
repulsion may also hinder the diffusion of NaF in the sclera.
Comparison with previous data:  The Stokes-Einstein
equation predicts that the diffusion coefficients of NaF (R=0.45
nm) in water at 4 °C and 37 °C are 2.89x10-6 cm2/s and 7.28x10-
6 cm2/s, respectively [15]. Ambati et al. [24] showed that the
permeability coefficient of NaF through rabbit sclera at 37 °C
was 8.45x10-5 cm/s and the thickness of the rabbit sclera was
416 mm. If one could assume that the transport experiment in
[24] is at the steady state, then the apparent diffusion coeffi-
cient was 3.5x10-6 cm2/s that is 48% of that in water at 37 °C.
Cheruvu and Kompella have shown that the permeability co-
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249efficient of NaF across the bovine sclera at 37 °C is 6.77x10-6
cm/s [25]. Treatment of the tissue with hydroxypropyl-b-
cyclodextrin (HPbCD) reduces the permeability coefficient to
3.33x10-6 cm/s. For HPbCD treated porcine sclera, the perme-
ability coefficient of NaF is 3.46x10-6 cm/s, which is approxi-
mately equal to that for HPbCD treated bovine sclera. If one
could assume that the thickness of porcine sclera is 1 mm and
that the transport experiment in [25] is at the steady state, then
the apparent diffusion coefficient of NaF in HPbCD treated
porcine sclera at 37 °C would be estimated as 3.46x10-7 cm2/s.
Furthermore, one could assume that the diffusion coefficient
of NaF at 4 °C is 39.7% as high as that at 37 °C, which is
predicted by the Stokes-Einstein equation mentioned above,
and that HPbCD treatment reduces the permeability coeffi-
cient of NaF by 50% [25]. Based on these assumptions, the
estimated diffusion coefficient of NaF in untreated porcine
sclera at 4 °C would be 2.79x10-7 cm2/s, which is on the same
order of magnitude as that measured in our experiment
(5.23x10-7 cm2/s).
In addition to NaF, the permeability coefficients of other
small molecules across different scleras have been reported in
the literature. Triamcinolone acetonide (TA; molecular weight,
434.5) is a steroid used for treating retinal diseases. It has been
delivered through the transscleral pathway [26,27]. The per-
meability coefficient of TA in human sclera at 22.5 °C is
1.47x10-5 cm/s [26]. The permeability and diffusion coeffi-
cients of sulforhodamine (molecular weight, 558) in human
sclera at 37 °C are 2.15x10-5 cm/s and 1.28x10-6 cm2/s, re-
spectively [13]. The permeability coefficients of sucrose (mo-
lecular weight, 342) in human sclera at 37 °C [28] and rabbit
sclera at room temperature [29] are 2.2x10-5 cm/s and 4.0x10-
5 cm/s, respectively. The same parameters at 37 °C are 1.8x10-
5 cm/s and 1.3x10-5 cm/s, respectively, for dexamethasone
(molecular weight, 392) and 1.2x10-5 cm/s and 1.3x10-5 cm/s,
respectively, for carboxyfluorescein (molecular weight, 342)
[30]. Although the molecular weights of these molecules are
similar to that of NaF, their permeability coefficients in rabbit
sclera are smaller than that reported in [24]. Mechanisms of
the discrepancy among these data remain to be investigated.
The permeability coefficient of macromolecules across
the sclera has also been reported in the literature. Aihara et al.
have shown that the permeability coefficient of FGF-2 (mo-
lecular weight, 17,000) across human sclera is 1.20±0.77x10-
8 cm/s, which is only 1.7% of that of 10 kDa dextran
(0.70±0.35x10-6 cm/s) [31]. The authors hypothesized that the
difference in the permeability coefficients was caused mainly
by nonspecific binding of FGF-2 to the extracellular matrix
within the sclera. Exposure of sclera to latanoprost acid [31]
or prostaglandins (PGs) [32] will result in an increase in the
permeability coefficient of macromolecules in a dose- and
time-dependent manner. The permeability increase is likely
to be due to an increase in matrix metalloproteinase activities
that may reduce the collagen content of the sclera [1,31,32].
Effects of convection and temperature on molecular trans-
port:  The height of the solution in the choroid chamber was
reduced by about 0.3 cm when 1 ml of ECA was removed
from the choroid chamber for measuring ECA concentration,
which caused a transient hydrostatic pressure difference across
the sclera at a level of about 0.23 mmHg. Previous studies
have shown that the pressure difference induces convective
transport in the sclera but the convection of small molecules
is negligible compared to their diffusion when the transscleral
pressure difference is <15 mmHg [30,33]. In addition, the to-
tal period of convection in our experiments was <4.5 min (each
measurement took <30 s and there were a total of 9 measure-
ments). When compared to the total period for diffusion (240
min), the duration of the transient process accounted for <2%
of the total experimental period. Taken together, the convec-
tion of ECA, induced by the transient hydrostatic pressure dif-
ference, had minimal contribution to the apparent diffusion
coefficient of ECA measured in this study.
The temperature in our experiments was maintained at 4
°C in order to minimize tissue degeneration. However, it is
well known that the diffusion coefficient is temperature-de-
pendent. Therefore, the diffusion coefficient measured in our
experiments needs to be multiplied by a factor in order to ob-
tain the value of the same parameter at 37 °C. The estimated
value of this factor is 2.5, as predicted by the Stokes-Einstein
equation mentioned above [15].
In summary, ECA diffused 8 times faster than NaF through
the porcine sclera and ECA diffusion was minimally hindered
by tissue structures. As a result, transscleral delivery of ECA
to the TM would be determined mainly by the concentration
of ECA at the episcleral surface and the rate of ECA clearance
at the TM. Results from this study may also be useful for
transscleral delivery of other TM drugs, following subcon-
junctival administration or intrascleral implantation of con-
trolled release devices [34,35].
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